Literature DB >> 4017418

The effects of several weeks of ethanol consumption on ethanol kinetics in normal men and women.

J L Holtzman, R L Gebhard, J H Eckfeldt, L R Mottonen, D K Finley, F N Eshelman.   

Abstract

We examined in normal men and women the effects of chronic ethanol consumption and the coadministration of cimetidine and ranitidine on the kinetics of ethanol. We found that the consumption of 45 gm ethanol per day for 3 weeks increased the apparent volume of distribution of ethanol in men from 732 to 884 ml/kg (P less than 0.01) but had no such effect in women (697 ml/kg before ethanol and 746 ml/kg after chronic ethanol consumption). This combined therapy had no effect on the rate of ethanol disappearance in either sex. In men the rate of disappearance was 165 mg/L/hr before and 168 mg/L/hr after chronic consumption, while in women the respective values were 209 and 203 mg/L/hr. The addition of either cimetidine or ranitidine had no effect on either parameter compared with values observed on day 22 of the study. In view of the known inhibitory effects of cimetidine on cytochrome P-450-dependent enzymes, our data suggest that this enzyme system does not metabolize a significant fraction of ingested ethanol in subjects who have consumed moderate doses of alcohol for several weeks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017418     DOI: 10.1038/clpt.1985.152

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans.

Authors:  B L Chauhan; R D Kulkarni
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of ethanol.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

Review 5.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 6.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

7.  Bias in alcohol and drug screening in adult burn patients.

Authors:  Felicia N Williams; Lori Chrisco; Paula D Strassle; Sarah L Laughon; Sanja Sljivic; Kamil Nurczyk; Rabia Nizamani; Booker T King; Anthony Charles
Journal:  Int J Burns Trauma       Date:  2020-08-15

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

9.  Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine.

Authors:  J G Van Rooij; M M Veeger; M M Bodelier-Bade; P T Scheepers; F J Jongeneelen
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

Review 10.  H2-antagonists and alcohol. Do they interact?

Authors:  R Gugler
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.